Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease.
about
Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMICorrelation of GLUT9 Polymorphisms With Gout RiskGout and Risk of Myocardial Infarction: A Systematic Review and Meta-Analysis of Cohort StudiesMechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and goutGene polymorphisms in association with emerging cardiovascular risk markers in adult womenFructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review.Sex-Specific Relationship Between Serum Uric Acid and Risk of Stroke: A Dose-Response Meta-Analysis of Prospective Studies.Allopurinol: insights from studies of dose-response relationships.Factors associated with persistent hypertension after puerperium among women with pre-eclampsia/eclampsia in Mulago hospital, Uganda.Plasmodium-induced inflammation by uric acidUric acid is a mediator of the Plasmodium falciparum-induced inflammatory response.Hyperuricemia and incident heart failure.A surprising role for uric acid: the inflammatory malaria response.Serum uric acid concentration is associated with hypertensive retinopathy in hypertensive chinese adults.Uric acid transport and diseaseUric acid levels are associated with microvascular endothelial dysfunction in patients with Type 1 diabetes.Role of metabolic syndrome components in human immunodeficiency virus-associated stroke.Fructose and cardiometabolic disorders: the controversy will, and must, continue.High plasma uric acid concentration: causes and consequences.Interaction of inflammation, hyperuricemia, and the prevalence of hypertension among adults free of metabolic syndrome: NHANES 2009-2010.Plasma uric acid levels correlate with inflammation and disease severity in Malian children with Plasmodium falciparum malariaPsoriasis, psoriatic arthritis and risk of gout in US men and women.A potential role for plasma uric acid in the endothelial pathology of Plasmodium falciparum malaria.Relationship between red cell distribution width and serum uric acid in patients with untreated essential hypertension.Uric acid promotes apoptosis in human proximal tubule cells by oxidative stress and the activation of NADPH oxidase NOX 4.Determinants of vascular function in patients with chronic gout.The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortalityCholesterol-cholate-butterfat diet offers multi-organ dysfunction in rats.Identification of systemic immune response markers through metabolomic profiling of plasma from calves given an intra-nasally delivered respiratory vaccine.Adiponectinemia is associated with uricemia but not with proinflammatory status in women with metabolic syndromeSerum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetesMetabolomics analysis reveals insights into biochemical mechanisms of mental stress-induced left ventricular dysfunction.A coronary artery disease-associated SNP rs6903956 contributed to asymptomatic hyperuricemia susceptibility in Han Chinese.Factors associated with early platelet activation in obese childrenThe association between serum uric acid levels, metabolic syndrome and cardiovascular disease in middle aged and elderly Chinese: results from the DYSlipidemia International StudyAssociation of Elevated Serum Uric Acid with the Components of Metabolic Syndrome and Oxidative Stress in Abdominal Obesity SubjectsUric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndromeUric Acid Levels Can Predict Metabolic Syndrome and Hypertension in Adolescents: A 10-Year Longitudinal Study.Evolutionary context for the association of γ-globin, serum uric acid, and hypertension in African Americans.Association of Glomerular Filtration Rate with Inflammation in Polycystic Ovary Syndrome
P2860
Q24649961-7924BB62-29A3-4E53-9CD8-DF82D0251B33Q26778204-ECF5E75B-27BD-49A8-91A9-827942700824Q26800933-CB0B726D-A635-4942-825E-0F2848850F24Q27023909-C8FF45B5-0DEC-48C1-8ECC-38C7DC0A4EF6Q28393721-5E834786-1198-4034-A281-E0F454F87218Q30234756-F78144DE-98D5-4A18-9102-7E1E30A255CFQ30235039-865FA6D1-4333-454B-88DF-60E0464608E6Q30240163-C534A452-7C71-4BBE-BEA5-21EEC2120580Q30979444-7C7EB8A0-2CE1-45E7-8D43-58918F19E32AQ33325912-EEFB177C-08AF-4F99-B713-592FF4173AA0Q33432736-E1CE090D-7AD4-49C6-86B0-FA128E52DFE7Q33572047-89331580-0912-4764-B775-D1CE9AAFE3CDQ33684119-2028AA76-E7AA-4ABA-8ABF-A0261442A024Q33759523-05079912-FF84-470E-AECE-832B02BAF15AQ33882958-89CF9930-8B58-4B7C-A3D4-4DA89961F345Q33928035-842E4F00-E97D-4568-A469-7C9FC058B042Q33938800-A99131BE-297B-492B-8C02-2614BFE3BE66Q34023494-8400E98B-C663-4164-A28F-9FBB73566F0CQ34265901-258D6EE6-C685-49E5-A61F-7ABFE80C8FE4Q34297252-399D3F0E-4385-4BA9-8CEE-3B9A6338B385Q34447127-242831D4-63CB-41E9-B61A-A8E59DC0EEDFQ34474068-6B779549-4305-41C7-B5FB-1D97E46605A3Q34563150-81652578-14C2-4CD6-828C-5603F4E6C2C1Q34616714-270C4304-CF84-4A92-A2B8-FD02041E20A7Q34713167-1C3DB278-E75D-438B-A3AD-C3B022F37BB4Q34788956-4217DA00-7405-4442-970A-BDCEBA76BF07Q34877729-24176B4E-AF13-4DC2-82B5-2BCC1F81ED8FQ34911107-8A503D12-7572-43C9-8E36-500F8A16E207Q35082519-58691AB9-A69A-4D28-B8C9-8811ABBB17BEQ35137712-3AC6717C-E86C-401A-B6AC-83BED53271D5Q35184941-CE8DBA1D-D8B8-40EA-8278-0E7845D26DFAQ35606621-DEFB1472-F829-43F4-A14F-5645F6A4694DQ35620405-15D80DFE-3956-4748-8B06-3E66E0D2259BQ35677121-2850397F-6673-4624-ACC3-F6A49B346881Q35687479-2892F782-DB19-41FC-9539-74B25512BD75Q35747103-63EAC48B-7992-4579-843A-2840BDA612E6Q35802376-B1882449-E81F-4770-A0A8-30D6AB8EBF67Q35855406-6B3332B4-C104-46A6-91B9-946BA0E1966BQ35873557-B427C356-0877-482F-9FF6-8BFCA7F83159Q35898943-F4EE8218-AA11-41D0-8A7D-3D1C9F14D8F4
P2860
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease.
@ast
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease.
@en
type
label
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease.
@ast
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease.
@en
prefLabel
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease.
@ast
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease.
@en
P1476
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease.
@en
P2093
Duk-Hee Kang
John Kanellis
P356
10.1016/J.SEMNEPHROL.2004.09.007
P577
2005-01-01T00:00:00Z